Tyvaso DPI
- Product NDC
- 66302-600
- 11-digit product format
- 663020600
- Labeler code
- 66302
- Product ID
- 66302-600_46c30322-3a4d-41f0-b7c1-1e4aba4831be
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- treprostinil
- Dosage form
- KIT
- Labeler
- United Therapeutics Corporation
- Application
- NDA214324
- Marketing category
- NDA
- Marketing start
- 2022-05-23
- Marketing end
- 0000-00-00
- Active strength
- 0
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 66302-600 | D | Discontinued by firm | 2026-09-09 | ||
| excluded package | package | 66302-600 | 66302-600-02 | D | Discontinued by firm | 2026-09-09 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | d630ba8d3edf… | 732f749b63fb… | |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 66302-600-02 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 66302-600-02 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 66302-600-02 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 66302-600-02 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 66302-600-02 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 66302-600-02 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 66302-600-02 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 66302-600-02 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 66302-600-02 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded product | product | ad56d346431e… | cc804d4bbf1e… | |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 66302-600-02 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded product | product | 367a005e9d99… | 383a685ebd0f… | |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 66302-600-02 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded product | product | 557ba5c1ecfa… | 9c80585c8c6e… | |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 66302-600-02 | 557ba5c1ecfa… | 9c80585c8c6e… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N214324-001 | TYVASO DPI | TREPROSTINIL | 0.016MG/INH | POWDER / INHALATION | RLD, RS | 2022-05-23 | |
| N214324-002 | TYVASO DPI | TREPROSTINIL | 0.032MG/INH | POWDER / INHALATION | RLD, RS | 2022-05-23 | |
| N214324-003 | TYVASO DPI | TREPROSTINIL | 0.048MG/INH | POWDER / INHALATION | RLD, RS | 2022-05-23 | |
| N214324-004 | TYVASO DPI | TREPROSTINIL | 0.064MG/INH | POWDER / INHALATION | RLD, RS | 2022-05-23 | |
| N214324-005 | TYVASO DPI | TREPROSTINIL | 0.08MG/INH | POWDER / INHALATION | RLD, RS | 2024-10-24 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N214324-001 | 11357782 | 2027-05-14 | U-1849 | 2025-04-24 | |
| N214324-001 | 11723887 | 2028-12-15 | Drug substance | 2023-08-15 | |
| N214324-001 | 9593066 | 2028-12-15 | Drug substance | 2022-06-17 | |
| N214324-001 | 10772883 | 2030-06-11 | Drug product | 2022-06-17 | |
| N214324-001 | 10421729 | 2035-04-01 | Drug product | 2022-06-17 | |
| N214324-001 | 11826327 | 2042-02-03 | U-3749 | 2023-11-28 | |
| N214324-002 | 11357782 | 2027-05-14 | U-1849 | 2025-04-24 | |
| N214324-002 | 11723887 | 2028-12-15 | Drug substance | 2023-08-15 | |
| N214324-002 | 9593066 | 2028-12-15 | Drug substance | 2022-06-17 | |
| N214324-002 | 10772883 | 2030-06-11 | Drug product | 2022-06-17 | |
| N214324-002 | 10421729 | 2035-04-01 | Drug product | 2022-06-17 | |
| N214324-002 | 11826327 | 2042-02-03 | U-3749 | 2023-11-28 | |
| N214324-003 | 11357782 | 2027-05-14 | U-1849 | 2025-04-24 | |
| N214324-003 | 11723887 | 2028-12-15 | Drug substance | 2023-08-15 | |
| N214324-003 | 9593066 | 2028-12-15 | Drug substance | 2022-06-17 | |
| N214324-003 | 10772883 | 2030-06-11 | Drug product | 2022-06-17 | |
| N214324-003 | 10421729 | 2035-04-01 | Drug product | 2022-06-17 | |
| N214324-003 | 11826327 | 2042-02-03 | U-3749 | 2023-11-28 | |
| N214324-004 | 11357782 | 2027-05-14 | U-1849 | 2025-04-24 | |
| N214324-004 | 11723887 | 2028-12-15 | Drug substance | 2023-08-15 | |
| N214324-004 | 9593066 | 2028-12-15 | Drug substance | 2022-06-17 | |
| N214324-004 | 10772883 | 2030-06-11 | Drug product | 2022-06-17 | |
| N214324-004 | 10421729 | 2035-04-01 | Drug product | 2022-06-17 | |
| N214324-004 | 11826327 | 2042-02-03 | U-3749 | 2023-11-28 | |
| N214324-005 | 11357782 | 2027-05-14 | U-1849 | 2025-04-24 | |
| N214324-005 | 11723887 | 2028-12-15 | Drug substance | 2024-11-18 | |
| N214324-005 | 9593066 | 2028-12-15 | Drug substance | 2024-11-18 | |
| N214324-005 | 10772883 | 2030-06-11 | Drug product | 2024-11-18 | |
| N214324-005 | 10421729 | 2035-04-01 | Drug product | 2024-11-18 | |
| N214324-005 | 11826327 | 2042-02-03 | U-3749 | 2024-11-18 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N214324-001 | TYVASO DPI | 0.016MG/INH | POWDER / INHALATION | RLD, RS | 2022-05-23 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N214324-002 | TYVASO DPI | 0.032MG/INH | POWDER / INHALATION | RLD, RS | 2022-05-23 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N214324-003 | TYVASO DPI | 0.048MG/INH | POWDER / INHALATION | RLD, RS | 2022-05-23 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N214324-004 | TYVASO DPI | 0.064MG/INH | POWDER / INHALATION | RLD, RS | 2022-05-23 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N214324-005 | TYVASO DPI | 0.08MG/INH | POWDER / INHALATION | RLD, RS | 2024-10-24 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214324-001 | TYVASO DPI | 0.016MG/INH | POWDER / INHALATION | RLD, RS | 2022-05-23 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214324-002 | TYVASO DPI | 0.032MG/INH | POWDER / INHALATION | RLD, RS | 2022-05-23 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214324-003 | TYVASO DPI | 0.048MG/INH | POWDER / INHALATION | RLD, RS | 2022-05-23 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214324-004 | TYVASO DPI | 0.064MG/INH | POWDER / INHALATION | RLD, RS | 2022-05-23 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214324-005 | TYVASO DPI | 0.08MG/INH | POWDER / INHALATION | RLD, RS | 2024-10-24 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214324-001 | TYVASO DPI | 0.016MG/INH | POWDER / INHALATION | RLD, RS | 2022-05-23 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214324-002 | TYVASO DPI | 0.032MG/INH | POWDER / INHALATION | RLD, RS | 2022-05-23 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214324-003 | TYVASO DPI | 0.048MG/INH | POWDER / INHALATION | RLD, RS | 2022-05-23 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214324-004 | TYVASO DPI | 0.064MG/INH | POWDER / INHALATION | RLD, RS | 2022-05-23 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214324-005 | TYVASO DPI | 0.08MG/INH | POWDER / INHALATION | RLD, RS | 2024-10-24 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N214324-001 | TYVASO DPI | 0.016MG/INH | POWDER / INHALATION | RLD, RS | 2022-05-23 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N214324-002 | TYVASO DPI | 0.032MG/INH | POWDER / INHALATION | RLD, RS | 2022-05-23 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N214324-003 | TYVASO DPI | 0.048MG/INH | POWDER / INHALATION | RLD, RS | 2022-05-23 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N214324-004 | TYVASO DPI | 0.064MG/INH | POWDER / INHALATION | RLD, RS | 2022-05-23 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N214324-005 | TYVASO DPI | 0.08MG/INH | POWDER / INHALATION | RLD, RS | 2024-10-24 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N214324-001 | TYVASO DPI | 0.016MG/INH | POWDER / INHALATION | RLD, RS | 2022-05-23 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N214324-002 | TYVASO DPI | 0.032MG/INH | POWDER / INHALATION | RLD, RS | 2022-05-23 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N214324-003 | TYVASO DPI | 0.048MG/INH | POWDER / INHALATION | RLD, RS | 2022-05-23 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N214324-004 | TYVASO DPI | 0.064MG/INH | POWDER / INHALATION | RLD, RS | 2022-05-23 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N214324-005 | TYVASO DPI | 0.08MG/INH | POWDER / INHALATION | RLD, RS | 2024-10-24 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N214324-001 | TYVASO DPI | 0.016MG/INH | POWDER / INHALATION | RLD, RS | 2022-05-23 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N214324-002 | TYVASO DPI | 0.032MG/INH | POWDER / INHALATION | RLD, RS | 2022-05-23 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N214324-003 | TYVASO DPI | 0.048MG/INH | POWDER / INHALATION | RLD, RS | 2022-05-23 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N214324-004 | TYVASO DPI | 0.064MG/INH | POWDER / INHALATION | RLD, RS | 2022-05-23 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N214324-005 | TYVASO DPI | 0.08MG/INH | POWDER / INHALATION | RLD, RS | 2024-10-24 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N214324-001 | TYVASO DPI | 0.016MG/INH | POWDER / INHALATION | RLD, RS | 2022-05-23 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N214324-002 | TYVASO DPI | 0.032MG/INH | POWDER / INHALATION | RLD | 2022-05-23 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N214324-003 | TYVASO DPI | 0.048MG/INH | POWDER / INHALATION | RLD | 2022-05-23 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N214324-004 | TYVASO DPI | 0.064MG/INH | POWDER / INHALATION | RLD, RS | 2022-05-23 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N214324-005 | TYVASO DPI | 0.08MG/INH | POWDER / INHALATION | RLD | 2024-10-24 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N214324-001 | TYVASO DPI | 0.016MG/INH | POWDER / INHALATION | RLD, RS | 2022-05-23 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N214324-002 | TYVASO DPI | 0.032MG/INH | POWDER / INHALATION | RLD | 2022-05-23 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N214324-003 | TYVASO DPI | 0.048MG/INH | POWDER / INHALATION | RLD | 2022-05-23 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N214324-004 | TYVASO DPI | 0.064MG/INH | POWDER / INHALATION | RLD, RS | 2022-05-23 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N214324-005 | TYVASO DPI | 0.08MG/INH | POWDER / INHALATION | RLD | 2024-10-24 | 2680178bc6a6… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N214324-001 | 11357782 | 2027-05-14 | U-1849 | 2025-04-24 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N214324-001 | 11723887 | 2028-12-15 | Drug substance | 2023-08-15 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N214324-001 | 9593066 | 2028-12-15 | Drug substance | 2022-06-17 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N214324-001 | 10772883 | 2030-06-11 | Drug product | 2022-06-17 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N214324-001 | 10421729 | 2035-04-01 | Drug product | 2022-06-17 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N214324-001 | 11826327 | 2042-02-03 | U-3749 | 2023-11-28 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N214324-002 | 11357782 | 2027-05-14 | U-1849 | 2025-04-24 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N214324-002 | 11723887 | 2028-12-15 | Drug substance | 2023-08-15 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N214324-002 | 9593066 | 2028-12-15 | Drug substance | 2022-06-17 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N214324-002 | 10772883 | 2030-06-11 | Drug product | 2022-06-17 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N214324-002 | 10421729 | 2035-04-01 | Drug product | 2022-06-17 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N214324-002 | 11826327 | 2042-02-03 | U-3749 | 2023-11-28 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N214324-003 | 11357782 | 2027-05-14 | U-1849 | 2025-04-24 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N214324-003 | 11723887 | 2028-12-15 | Drug substance | 2023-08-15 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N214324-003 | 9593066 | 2028-12-15 | Drug substance | 2022-06-17 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N214324-003 | 10772883 | 2030-06-11 | Drug product | 2022-06-17 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N214324-003 | 10421729 | 2035-04-01 | Drug product | 2022-06-17 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N214324-003 | 11826327 | 2042-02-03 | U-3749 | 2023-11-28 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N214324-004 | 11357782 | 2027-05-14 | U-1849 | 2025-04-24 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N214324-004 | 11723887 | 2028-12-15 | Drug substance | 2023-08-15 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N214324-004 | 9593066 | 2028-12-15 | Drug substance | 2022-06-17 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N214324-004 | 10772883 | 2030-06-11 | Drug product | 2022-06-17 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N214324-004 | 10421729 | 2035-04-01 | Drug product | 2022-06-17 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N214324-004 | 11826327 | 2042-02-03 | U-3749 | 2023-11-28 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N214324-005 | 11357782 | 2027-05-14 | U-1849 | 2025-04-24 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N214324-005 | 11723887 | 2028-12-15 | Drug substance | 2024-11-18 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N214324-005 | 9593066 | 2028-12-15 | Drug substance | 2024-11-18 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N214324-005 | 10772883 | 2030-06-11 | Drug product | 2024-11-18 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N214324-005 | 10421729 | 2035-04-01 | Drug product | 2024-11-18 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N214324-005 | 11826327 | 2042-02-03 | U-3749 | 2024-11-18 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214324-001 | 11357782 | 2027-05-14 | U-1849 | 2025-04-24 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214324-001 | 11723887 | 2028-12-15 | Drug substance | 2023-08-15 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214324-001 | 9593066 | 2028-12-15 | Drug substance | 2022-06-17 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214324-001 | 10772883 | 2030-06-11 | Drug product | 2022-06-17 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214324-001 | 10421729 | 2035-04-01 | Drug product | 2022-06-17 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214324-001 | 11826327 | 2042-02-03 | U-3749 | 2023-11-28 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214324-002 | 11357782 | 2027-05-14 | U-1849 | 2025-04-24 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214324-002 | 11723887 | 2028-12-15 | Drug substance | 2023-08-15 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214324-002 | 9593066 | 2028-12-15 | Drug substance | 2022-06-17 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214324-002 | 10772883 | 2030-06-11 | Drug product | 2022-06-17 | 011fe1cb6892… |
Observed Orange Book exclusivity history#
| Captured | Edition | Application-product | Exclusivity code | Expiration | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214324-001 | NP | 2025-05-23 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214324-002 | NP | 2025-05-23 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214324-003 | NP | 2025-05-23 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214324-004 | NP | 2025-05-23 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N214324-001 | NP | 2025-05-23 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N214324-002 | NP | 2025-05-23 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N214324-003 | NP | 2025-05-23 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N214324-004 | NP | 2025-05-23 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N214324-001 | NP | 2025-05-23 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N214324-002 | NP | 2025-05-23 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N214324-003 | NP | 2025-05-23 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N214324-004 | NP | 2025-05-23 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N214324-001 | NP | 2025-05-23 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N214324-002 | NP | 2025-05-23 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N214324-003 | NP | 2025-05-23 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N214324-004 | NP | 2025-05-23 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N214324-001 | NP | 2025-05-23 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N214324-002 | NP | 2025-05-23 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N214324-003 | NP | 2025-05-23 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N214324-004 | NP | 2025-05-23 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N214324-001 | NP | 2025-05-23 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N214324-002 | NP | 2025-05-23 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N214324-003 | NP | 2025-05-23 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N214324-004 | NP | 2025-05-23 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N214324-001 | NP | 2025-05-23 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N214324-002 | NP | 2025-05-23 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N214324-003 | NP | 2025-05-23 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N214324-004 | NP | 2025-05-23 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N214324-001 | NP | 2025-05-23 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N214324-002 | NP | 2025-05-23 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N214324-003 | NP | 2025-05-23 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N214324-004 | NP | 2025-05-23 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N214324-001 | NP | 2025-05-23 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N214324-002 | NP | 2025-05-23 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N214324-003 | NP | 2025-05-23 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N214324-004 | NP | 2025-05-23 | d06236e962d9… |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| d31d7280-9cbd-4e8c-ad8c-a830d9d6c4bf | Product name | 1 | 20260309 |
| 3a764347-294a-401b-979f-44c1c6bb101a | Product name | 1 | 20230126 |
| 5e14eefc-ad08-9fbf-a28c-67c518b16369 | Product name | 5 | 20210727 |
| 799cd7a2-692a-4730-993b-8b702e954a56 | Product name | 1 | 20200407 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 66302-600-02 | Tyvaso DPI | 1 in 1 PACKAGE | KIT | 1 | 14 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 66302-600-02 | EA - Each | 66302-600 | 12be41cd-f06c-4a20-a0f3-104f7b31f67c | 1 | 2022-07-06 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Tyvaso DPI | TREPROSTINIL | United Therapeutics Corporation | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 2025-11-20 | Warnings, Adverse reactions | 214324 NDA214324 66302-600 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 2602770 | {112 (treprostinil 0.016 MG Inhalation Powder [Tyvaso]) / 112 (treprostinil 0.032 MG Inhalation Powder [Tyvaso]) / 28 (treprostinil 0.048 MG Inhalation Powder [Tyvaso]) } Pack [Tyvaso 16-32-48 MCG Titration Pack] | BPCK | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2641914 | {112 (treprostinil 0.016 MG Inhalation Powder [Tyvaso]) / 112 (treprostinil 0.048 MG Inhalation Powder [Tyvaso]) / 112 (treprostinil 0.064 MG Inhalation Powder [Tyvaso]) } Pack [Tyvaso 16-48-64 MCG Maintenance Pack] | BPCK | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2602768 | {112 (treprostinil 0.016 MG Inhalation Powder [Tyvaso]) / 84 (treprostinil 0.032 MG Inhalation Powder [Tyvaso]) } Pack [Tyvaso 16-32 MCG Titration Pack] | BPCK | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2602774 | {112 (treprostinil 0.032 MG Inhalation Powder [Tyvaso]) / 112 (treprostinil 0.048 MG Inhalation Powder [Tyvaso]) } Pack [Tyvaso 32-48 MCG Maintenance Pack] | BPCK | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2641907 | {112 (treprostinil 0.032 MG Inhalation Powder [Tyvaso]) / 112 (treprostinil 0.064 MG Inhalation Powder [Tyvaso]) } Pack [Tyvaso 32-64 MCG Maintenance Pack] | BPCK | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2641912 | {112 (treprostinil 0.048 MG Inhalation Powder [Tyvaso]) / 112 (treprostinil 0.064 MG Inhalation Powder [Tyvaso]) } Pack [Tyvaso 48-64 MCG Maintenance Pack] | BPCK | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2727471 | {112 (treprostinil 0.048 MG Inhalation Powder [Tyvaso]) / 112 (treprostinil 0.08 MG Inhalation Powder [Tyvaso]) } Pack [Tyvaso 48-80 MCG Maintenance Pack] | BPCK | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2727473 | {112 (treprostinil 0.064 MG Inhalation Powder [Tyvaso]) / 112 (treprostinil 0.08 MG Inhalation Powder [Tyvaso]) } Pack [Tyvaso 64-80 MCG Maintenance Pack] | BPCK | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2602772 | {16 (treprostinil 0.032 MG Inhalation Powder [Tyvaso]) / 16 (treprostinil 0.048 MG Inhalation Powder [Tyvaso]) } Pack [Tyvaso 32-48 MCG Institutional Pack] | BPCK | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2602769 | {112 (treprostinil 0.016 MG Inhalation Powder) / 112 (treprostinil 0.032 MG Inhalation Powder) / 28 (treprostinil 0.048 MG Inhalation Powder) } Pack | GPCK | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2641913 | {112 (treprostinil 0.016 MG Inhalation Powder) / 112 (treprostinil 0.048 MG Inhalation Powder) / 112 (treprostinil 0.064 MG Inhalation Powder) } Pack | GPCK | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2602767 | {112 (treprostinil 0.016 MG Inhalation Powder) / 84 (treprostinil 0.032 MG Inhalation Powder) } Pack | GPCK | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2602773 | {112 (treprostinil 0.032 MG Inhalation Powder) / 112 (treprostinil 0.048 MG Inhalation Powder) } Pack | GPCK | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2641906 | {112 (treprostinil 0.032 MG Inhalation Powder) / 112 (treprostinil 0.064 MG Inhalation Powder) } Pack | GPCK | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2641911 | {112 (treprostinil 0.048 MG Inhalation Powder) / 112 (treprostinil 0.064 MG Inhalation Powder) } Pack | GPCK | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2727470 | {112 (treprostinil 0.048 MG Inhalation Powder) / 112 (treprostinil 0.08 MG Inhalation Powder) } Pack | GPCK | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2727472 | {112 (treprostinil 0.064 MG Inhalation Powder) / 112 (treprostinil 0.08 MG Inhalation Powder) } Pack | GPCK | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2602771 | {16 (treprostinil 0.032 MG Inhalation Powder) / 16 (treprostinil 0.048 MG Inhalation Powder) } Pack | GPCK | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2602751 | treprostinil 16 MCG Inhalation Powder | PSN | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2602767 | treprostinil 16-32 MCG Titration Pack, 112 (16 MCG), 84 (32 MCG) | PSN | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2602769 | treprostinil 16-32-48 MCG Titration Pack, 112 (16 MCG), 112 (32 MCG), 28 (48 MCG) | PSN | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2641913 | treprostinil 16-48-64 MCG Maintenance Pack, 112 (16 MCG), 112 (48 MCG), 112 (64 MCG) | PSN | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2602756 | treprostinil 32 MCG Inhalation Powder | PSN | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2602771 | treprostinil 32-48 MCG Institutional Pack, 16 (32 MCG), 16 (48 MCG) | PSN | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2602773 | treprostinil 32-48 MCG Maintenance Pack, 112 (32 MCG), 112 (48 MCG) | PSN | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2641906 | treprostinil 32-64 MCG Maintenance Pack, 112 (32 MCG), 112 (64 MCG) | PSN | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2602760 | treprostinil 48 MCG Inhalation Powder | PSN | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2641911 | treprostinil 48-64 MCG Maintenance Pack, 112 (48 MCG), 112 (64 MCG) | PSN | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2727470 | treprostinil 48-80 MCG Titration Pack, 112 (48 MCG), 112 (80 MCG) | PSN | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2602764 | treprostinil 64 MCG Inhalation Powder | PSN | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2727472 | treprostinil 64-80 MCG Titration Pack, 112 (64 MCG), 112 (80 MCG) | PSN | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2697737 | treprostinil 80 MCG Inhalation Powder | PSN | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2602754 | TYVASO DPI 16 MCG Inhalation Powder | PSN | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2602768 | Tyvaso DPI 16-32 MCG Titration Pack | PSN | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2602770 | Tyvaso DPI 16-32-48 MCG Titration Pack | PSN | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2641914 | Tyvaso DPI 16-48-64 MCG Maintenance Pack | PSN | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2602758 | TYVASO DPI 32 MCG Inhalation Powder | PSN | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2602772 | Tyvaso DPI 32-48 MCG Institutional Pack | PSN | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2602774 | Tyvaso DPI 32-48 MCG Maintenance Pack | PSN | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2641907 | Tyvaso DPI 32-64 MCG Maintenance Pack | PSN | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2602762 | TYVASO DPI 48 MCG Inhalation Powder | PSN | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2641912 | Tyvaso DPI 48-64 MCG Maintenance Pack | PSN | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2727471 | Tyvaso DPI 48-80 MCG Maintenance Pack | PSN | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2602766 | TYVASO DPI 64 MCG Inhalation Powder | PSN | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2727473 | Tyvaso DPI 64-80 MCG Maintenance Pack | PSN | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2697739 | TYVASO DPI 80 MCG Inhalation Powder | PSN | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2602754 | treprostinil 0.016 MG Inhalation Powder [Tyvaso] | SBD | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2602758 | treprostinil 0.032 MG Inhalation Powder [Tyvaso] | SBD | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2602762 | treprostinil 0.048 MG Inhalation Powder [Tyvaso] | SBD | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2602766 | treprostinil 0.064 MG Inhalation Powder [Tyvaso] | SBD | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2697739 | treprostinil 0.08 MG Inhalation Powder [Tyvaso] | SBD | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2602751 | treprostinil 0.016 MG Inhalation Powder | SCD | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2602756 | treprostinil 0.032 MG Inhalation Powder | SCD | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2602760 | treprostinil 0.048 MG Inhalation Powder | SCD | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2602764 | treprostinil 0.064 MG Inhalation Powder | SCD | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2697737 | treprostinil 0.08 MG Inhalation Powder | SCD | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2602751 | treprostinil 16 MCG Inhalation Powder | SY | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2602767 | treprostinil 16-32 MCG Titration Pack, 112 (16 MCG), 84 (32 MCG) | SY | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2602769 | treprostinil 16-32-48 MCG Titration Pack, 112 (16 MCG), 112 (32 MCG), 28 (48 MCG) | SY | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2641913 | treprostinil 16-48-64 MCG Maintenance Pack, 112 (16 MCG), 112 (48 MCG), 112 (64 MCG) | SY | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2602756 | treprostinil 32 MCG Inhalation Powder | SY | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2602771 | treprostinil 32-48 MCG Institutional Pack, 16 (32 MCG), 16 (48 MCG) | SY | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2602773 | treprostinil 32-48 MCG Maintenance Pack, 112 (32 MCG), 112 (48 MCG) | SY | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2641906 | treprostinil 32-64 MCG Maintenance Pack, 112 (32 MCG), 112 (64 MCG) | SY | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2602760 | treprostinil 48 MCG Inhalation Powder | SY | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2641911 | treprostinil 48-64 MCG Maintenance Pack, 112 (48 MCG), 112 (64 MCG) | SY | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2727470 | treprostinil 48-80 MCG Titration Pack, 112 (48 MCG), 112 (80 MCG) | SY | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2602764 | treprostinil 64 MCG Inhalation Powder | SY | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2727472 | treprostinil 64-80 MCG Titration Pack, 112 (64 MCG), 112 (80 MCG) | SY | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2697737 | treprostinil 80 MCG Inhalation Powder | SY | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2602754 | Tyvaso 0.016 MG Inhalation Powder | SY | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2602758 | Tyvaso 0.032 MG Inhalation Powder | SY | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2602762 | Tyvaso 0.048 MG Inhalation Powder | SY | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2602766 | Tyvaso 0.064 MG Inhalation Powder | SY | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2697739 | Tyvaso 0.08 MG Inhalation Powder | SY | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2602754 | Tyvaso 16 MCG Inhalation Powder | SY | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2602758 | Tyvaso 32 MCG Inhalation Powder | SY | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2602762 | Tyvaso 48 MCG Inhalation Powder | SY | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2602766 | Tyvaso 64 MCG Inhalation Powder | SY | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
| 2697739 | Tyvaso 80 MCG Inhalation Powder | SY | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 14 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 66302-600-02 | 66302060002 | 1 KIT in 1 PACKAGE (66302-600-02) * 4 INHALANT in 1 BLISTER PACK * 4 INHALANT in 1 BLISTER PACK | 1 kit | 2022-05-23 | 0000-00-00 | No | No | Current |